The effect of salbutamol in treatment of transient tachypnea of newbor
Not Applicable
- Conditions
- Transient tachypnea of newborn.Transient tachypnea of newborn
- Registration Number
- IRCT2014062518232N1
- Lead Sponsor
- Vice chancellor for research, Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Inclusion criteria:
The late preterm (gestational age of 34 – 37 weeks) and term (gestational ageof 37 -42 weeks) and post term (gestational age greater than 42 weeks) neonates with tachypnea (Respiratory Rate greater than 60 per minute) with or without respiratory distress within 6 hours of birth.
Exclusion criteria:
Pretem neonates (gestational age less than 34 weeks); neonates with history of asphyxia; birth trauma; meconium aspiration syndrome; congenital pneumonia; a history of chorioamnionitis or corticosteroids therapy in mother; gross congenital anomaly and neonates with tachycardia; arythmia; blood culture or CRP positive during treatment will be excluded.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tachypnea. Timepoint: before intervention; 30 minute, one, four, six hours later. Method of measurement: observation and record of respirtory rate per minute.
- Secondary Outcome Measures
Name Time Method